This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
21 CFR Part 11 is a crucial component of regulatory compliance in clinicaltrials and, more broadly, any industry subject to the regulations of the U.S. This blog post will serve as a comprehensive guide to understanding and implementing 21 CFR Part 11 compliance in your clinicaltrials. Let’s explore.
The clinical research industry is in the midst of a digital revolution, with ClinicalTrialManagement Software (CTMS) at the forefront of this transformation. The Early Days: Legacy CTMS Systems In the early days of clinical research, managingtrials was a manual, paper-based process.
Central labs ensure consistency in test methodologies, equipment and reporting standards, which is vital for the integrity of clinicaltrials. Accurate and reliable lab data play a crucial role in any clinicaltrial. The processes do not simply involve receiving a sample, testing it and producing a result, he says.
Study Execution and Monitoring: Our system facilitates real-time tracking of study progress, monitoring of clinicaltrial sites, and management of investigator performance. The guidance notes, “Information from pharmaceutical development studies can be a basis for quality risk management” (p.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content